Fintech PR
CoinShares Announces 2021 Interim Financial Results
CoinShares International Limited (Nasdaq First North Growth Market: CS) (“CoinShares”, the “Group” or the “Company”) today released its interim financial results for the six months ended 30 June 2021.
The full report, which is linked in this press release, can also be found on the CoinShares Investor Relations site.
2021 Interim Financial Results Highlights
- Total comprehensive income of £58.7 million.
(H1 2020: £10.4 million, FY2020: £18.4 million). - Adjusted EBITDA of £62.8 million, achieving a margin of 85%.
(H1 2020: £8.6 million / 58%, FY2020: £22.1 million / 63%). - Management fees generated by the Group’s Asset Management Platform of £36.7 million.
(H1 2020: £6.7 million, FY2020: £18.4 million). - Income and gains generated by the Group’s Capital Markets of £37.4 million
(H1 2020: £8.0 million, FY2020: £16.8 million). - Fair value gains on Principal Investments of £4.1 million.
(H1 2020: £0.4 million, FY2020: £1.0 million). - Assets under Management (“AUM”) as at 30 June 2021 of £2.2 billion.
(31 December 2020: £1.7 billion). - Net asset position of the Group as at 30 June 2021 of £128.3 million.
(31 December 2020: £56.5 million).
Commenting on today’s results, Jean-Marie Mognetti, Chief Executive Officer of CoinShares stated, “Following an exceptionally strong Q1 report, we have built on that momentum and reported the strongest Q2 in our Group’s history. This was accomplished despite the market volatility and digital asset price erosion reinforcing our view that CoinShares, Europe’s largest and longest standing Digital Asset Firm, is much more than a beta play on digital assets. Our Asset Management Platform business increased over 99% and our Capital Markets Infrastructure business increased over 122%, compared to 2020 year-end and significantly higher year-on-year. This strong performance led to an EBITDA improvement of 184% compared to 2020 year-end, in only a six-month period. With the new products brought to market, new exchange listings and new alliances formed, coupled with our acquisition of the ETF business from Elwood Technologies, we are well positioned to keep improving the earnings power of our Company.”
Mr. Mognetti continued, “We are now in what I believe is the best corporate and financial position we have ever been in and have a lot of exciting opportunities ahead to improve our business and drive shareholder value.”
2021 Interim Financial Results Summary
Following the Group’s record Q1 results as announced on 24 May 2021, CoinShares has achieved a record Q2, resulting in the strongest interim performance in the Group’s history. This performance has been primarily driven by Bitcoin and Ethereum prices reaching all-time highs in April and May 2021, respectively. This has resulted in increased management fees across the Group’s Asset Management Platform.
The volatility that accompanied these price increases, and the subsequent volatility of the declines seen in the latter part of May, continuing into June, resulted in market conditions that the Group was able to benefit from. Delta neutral trading strategies, fixed income activities and liquidity provisioning for the Company’s own products all contributed to the strong performance of the Group’s Capital Markets Infrastructure.
2021 Interim Commercial and Operational Highlights
- Expanded our footprint into the equities market with the acquisition of the ETF index business from Elwood Technologies, as announced on 6 July 2021, establishing a partnership with Invesco to further bridge the gap between traditional asset management and cryptocurrencies, whilst broadening both firms’ connectivity with global institutional investors and allocators.1
- Reached record trading volumes across our two ETP platforms on 19 May 2021, with more than $490m in CoinShares ETPs changing hands in a single day, being the highest volume of any European crypto ETP provider.2 These volumes demonstrated the robustness of the CoinShares Asset Management platform, which continued to operate seamlessly during volatile periods when several crypto exchanges halted trading.
- On 7 June 2021, CoinShares announced that three of its physically backed ETPs (CoinShares Physical Bitcoin, Ethereum and Litecoin ETPs) cross-listed on Germany’s Börse Xetra exchange.3
- This was followed on 21 June 2021 with an exclusive crypto ETP platform partnership with Finanzen.net, the largest platform for German-language financial and investment news. As a result of the partnership, CoinShares will be the sole provider of physically-backed crypto products on the newly launched investment platform finanzen.net “zero”.4
- Collaborated with 3iQ to launch the 3iQ CoinShares Bitcoin ETF5 and Ether ETF6 which are both publicly listed on the Canadian market.
- CoinShares and the DeFi Alliance extended their partnership, launching a new chapter in Europe with CoinShares serving as a founding partner.7 This alliance brings together other leading European crypto companies with a vision of supporting European DeFi startups with capital and liquidity and collaboration with partners to build a robust DeFi ecosystem in Europe.
- Partnership with Blockdaemon, the leading institutional crypto infrastructure provider and largest independent blockchain infrastructure platform, to build staking and blockchain networking infrastructure into its larger trading and asset management platform.7
- Strategic investment into a new ESG-focused investment management company in the United States, Viridi Funds.8 The Viridi Cleaner Energy Crypto-Mining & Semiconductor ETF (NYSE: RIGZ) commenced trading on 20 July 2021.
The Company will hold a webcast on Thursday, 5 August 2021 at 3:00 pm BST (10:00 am ET) to discuss the results for the second quarter and interim period ending 30 June 2021. The live webcast of the earnings conference call can be accessed on the investor relations section of the CoinShares website at http://coinshares.com/investor-relations. A replay of the webcast will be available online approximately 2 hours following the live call for a period of 30 days.
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
DEMAND AT ASIAN FACTORIES RISES AT STRONGEST RATE IN OVER 2 YEARS, IMPROVING NEAR-TERM GROWTH OUTLOOK FOR MANUFACTURING WORLDWIDE: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
-
Latest News6 days ago
Bitrue Gears Up for 2024 Bitcoin Halving with Trading Competition
-
Latest News6 days ago
Global Airlines Appoints New Head of Finance from KPMG
-
Latest News5 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News6 days ago
Spendesk combines procurement with spend management through Okko acquisition
-
Latest News6 days ago
BtcTurk Organizes Half Marathon in Istanbul to Celebrate Halving Period
-
Latest News3 days ago
Millions of people unite around doing good on the 18th International Good Deeds Day held yesterday worldwide
-
Latest News7 days ago
99Bitcoins Reveals Website Revamp and Expansion Plans With Incentivized Learning Through Tokenization